Portfolio company
Carisma Theraputics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops engineered macrophage and monocyte cell therapies for patients with solid tumours, liver fibrosis and other serious diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
CARISMA Therapeutics
This company develops engineered macrophage and monocyte cell therapies to treat patients with solid tumours and liver fibrosis.
Macomics
The company develops macrophage-modulating antibody therapies and precision medicines for patients with cancer and fibrotic diseases.
Resolution Therapeutics
Resolution Therapeutics develops macrophage cell therapies to treat patients with inflammatory and fibrotic diseases such as end-stage liver disease.
Verismo Therapeutics
This company develops chimeric antigen receptor therapies for patients with solid tumours and B-cell lymphomas.
Signadori Bio
This biopharmaceutical company develops a monocyte-based cell therapy platform to treat patients with solid tumours.
CARGO Therapeutics
This biotechnology company develops engineered cell therapies to treat cancer patients with relapsed or resistant lymphoma.
CREATE Medicines
The company develops in vivo CAR therapies using an mRNA platform to treat patients with cancer, autoimmune diseases, and fibrosis.
Actym Therapeutics
This biotechnology company develops bacterial immunotherapies to treat solid tumours and fibrotic diseases for patients with advanced cancers.